JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, X.
Right arrow Articles by Lu, A-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, X.
Right arrow Articles by Lu, A-L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 12, 8448-8455, March 24, 2000


The C-terminal Domain of MutY Glycosylase Determines the 7,8-Dihydro-8-oxo-guanine Specificity and Is Crucial for Mutation Avoidance*

Xianghong Li, Patrick M. Wright, and A-Lien LuDagger

From the Department of Biochemistry and Molecular Biology, University of Maryland at Baltimore, Baltimore, Maryland 21201

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Escherichia coli MutY is an adenine DNA glycosylase active on DNA substrates containing A/G, A/8-oxoG, or A/C mismatches and also has a weak guanine glycosylase activity on G/8-oxoG-containing DNA. The N-terminal domain of MutY, residues 1-226, has been shown to retain catalytic activity. Substrate binding, glycosylase, and Schiff base intermediate formation activities of the truncated and intact MutY were compared. MutY has high binding affinity with 8-oxoG when mispaired with A, G, T, C, or inosine. The truncated protein has more than 18-fold lower affinities for binding various 8-oxoG-containing mismatches when compared with intact MutY. MutY catalytic activity toward A/8-oxoG-containing DNA is much faster than that on A/G-containing DNA whereas deletion of the C-terminal domain reduces its catalytic preference for A/8-oxoG-DNA over A/G-DNA. MutY exerts more inhibition on the catalytic activity of MutM (Fpg) protein than does truncated MutY. The tight binding of MutY with GO mispaired with T, G, and apurinic/apyrimidinic sites may be involved in the regulation of MutM activity. An E. coli mutY strain that produces an N-terminal 249-residue truncated MutY confers a mutator phenotype. These findings strongly suggest that the C-terminal domain of MutY determines the 8-oxoG specificity and is crucial for mutation avoidance by oxidative damage.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The short-patch MutY repair pathway of Escherichia coli specifically repairs A/GO and A/G to C/GO and C:G, respectively, and corrects A/C to G:C at a much lower rate (1-7). The MutY protein along with MutM and MutT is involved in defending against the mutagenic effects of 7,8-dihydro-8-oxo-guanine (8-oxoG or GO)1 lesions, the most stable products formed due to oxidative damage to DNA (8, 9). The MutT protein eliminates 8-oxo-dGTP from the nucleotide pool with its nucleoside triphosphatase activity (10-12). The MutM glycosylase (Fpg protein) provides a second level of defense by removing both ring-opened purine lesions and mutagenic GO adducts (13, 14). When C/GO is not repaired by MutM, adenines are frequently incorporated opposite GO bases during DNA replication (15, 16). A second round of replication through this mismatch subsequently leads to a G:C to T:A transversion (16-19). MutY provides a third level of defense by removing the adenines misincorporated opposite GO or G following DNA replication (3, 8, 20).

The MutY protein is a 39-kDa iron-sulfur protein (7, 21, 22) with its N-terminal domain sharing structural similarity with endonuclease III (endo III) and AlkA (7, 21-24). This includes the helix-hairpin-helix and Gly/Pro ... Asp loop motifs. Endonuclease III repairs thymine glycol and oxidized pyrimidines in DNA (25, 26) and AlkA repairs methylated purines (27, 28). The conserved Asp acts as a general base to activate a nucleophile such as Lys or water. DNA glycosylases in the endo III superfamily can be divided into two groups (29, 30). Bifunctional DNA glycosylases, including endo III and OGG1, use the conserved lysine (Lys120 in endo III and Lys249 in hOGG1) to form a Schiff base intermediate and also possess strong AP lyase activity (23, 31-33). Monofunctional glycosylases such as AlkA lack both the conserved lysine and AP lyase activity (27, 28, 34). Because MutY does not have the conserved lysine downstream of the helix-hairpin-helix motif (Lys120 in endo III and Lys249 in hOGG1), it was originally grouped as a monofunctional glycosylase (34, 35) in the endo III superfamily. The possession of apurinic/apyrimidinic (AP) lyase activity by MutY is controversial. The MutY AP lyase activity was detected by some groups (7, 20, 36-40) but not by other groups (3, 4, 34, 35, 41). However, there is supporting evidence that MutY may be a bifunctional glycosylase. MutY can form a covalent complex with its DNA substrates (37-39, 42, 43), a diagnostic tool for bifunctional glycosylase/AP lyases (29, 33, 34). Several reports have shown that the Schiff base intermediate formation involves Lys142 (43-45), however, the K142A mutant MutY has glycosylase activity (44, 45) and can promote a beta /delta -elimination on AP-containing DNA (45). MutY can also cleave DNA containing an unmodified AP site (37, 45). Thus, MutY represents a unique group of glycosylases.

The structure and function of MutY have revealed several interesting aspects. Ethylation interference studies showed that MutY interacts with at least five phosphate groups and covers about 12 base pairs around the A/G mismatch (20). Methylation interference experiments have demonstrated that MutY specifically interacts with both mispaired A and G as well as the two bases flanking the A/G mismatch (20). This may explain the neighboring sequence effect on the repair efficiency of MutY. The MutY domain structure has been studied through proteolysis (37, 39, 40) and site-directed mutagenesis (24, 38, 46). The N-terminal domains of MutY, residues 1-226 (M25) (39, 47), and residues 1-225 (cdMutY or p26) (37, 40) have been shown to retain catalytic activity. Recently, the x-ray crystal structure of the catalytic domain of MutY(D138N) (cdMutY) with bound adenine shows that the adenine is buried in the active site of the catalytic domain and suggests that the mismatched adenine must flip out of the DNA helix for the glycosylase action (24). In the active site pocket, several amino acids (Gln182, Glu37, and Asp186) are involved in adenine binding.

The crystal structure of the N-terminal domains of MutY also suggests some candidate residues for the recognition of the base opposite adenine. We and Clarke's group (39, 47) have shown that the C-terminal domain of MutY plays an important role in the recognition of GO lesions while Manuel and Lloyd (37) have not drawn the same conclusion. In this paper, we further investigated the role of the C-terminal domain of MutY. The truncated MutY construct, M25, has more than 18-fold lower affinities for binding 8-oxoG-containing mismatches tested, as compared with intact MutY. Deletion of the C-terminal domain reduces its catalytic preference for A/GO-DNA over A/G-DNA. MutY also exerted more inhibition on the catalytic activity of MutM (Fpg) protein than M25. Moreover, an E. coli mutY strain that produces an N-terminal 249-residue truncated MutY is a mutator. These findings strongly support the notion that repair of 8-oxoG is the major function of MutY and its 8-oxoG specificity is located mainly in the C-terminal domain.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

E. coli Strains-- E. coli PR8 (Su- lacZ X74 galU galK Smr), PR70 (like PR8 but micA68::Tn10Kan), and PR68 (like PR8 but micA68::mini Tn10Kan mutL218::Tn10) were obtained from M. S. Fox.

Cloning of the N-terminal Domain of mutY Gene-- The N-terminal domain of the mutY gene corresponding to Met1 to Gln226 (M25) was polymerase chain reaction amplified from the pJTW10-12 plasmid (7) using primers Chang 222 (5'-GCGACGCATATGCAAGCGTCGCAATTTTC-3') and Chang 223 (5'-GCCGGAGGATCCCTACTGTTTCGGTTTTTTGCCCG-3'). Primer Chang 222 contains an NdeI site at the 5' end of the coding sequence and primer Chang 223 contains a BamHI site after the stop codon. The polymerase chain reaction product was purified from agarose gels, cut with NdeI and BamHI, and cloned into an NdeI/BamHI-digested pET11a expression vector. The inserted MutY sequence in the resulting clone pJ16-146-13 was confirmed by DNA sequencing. The expression of M25 was under the control of the T7 promoter. The expression host of the mutY mutants, PR70 harboring the lambda DE3 lysogen, was constructed according to the procedures described by Invitrogen.

Expression and Purification of M25 and MutY-- E. coli strain PR70/DE3 harboring the expression plasmid containing M25 was grown in LB broth containing 50 µg/ml ampicillin at 37 °C. The expression of the protein was induced at an A590 of 0.6 by the addition of isopropyl-1-thio-beta -D-galactopyranoside to a final concentration of 0.4 mM to the culture at 20 °C. The cells were harvested 16 h later.

The M25 domain was purified from 40 g of E. coli PR70/DE3 cells harboring the overproduction plasmid, similar to the method used with wild-type enzyme (7). Nicking of A/G-containing 20-mer DNA was monitored during the M25 protein purification. As judged on a 12% SDS-polyacrylamide gel, M25 was purified to >99% homogeneity (data not shown). The purification of homogeneous MutY protein from an overproducing E. coli JM109 strain, harboring pJTW10-12, has been described previously (7).

Expression and Purification of MutM-- The E. coli mutM gene was polymerase chain reaction amplified from the pFPG60 plasmid (7, 48) using primers Chang 180 (5'-GCCGGAATTCGGAGATGCTATGCCTGAATT-3') and Chang 181 (5'-GCCGGAATTCTTACTTCTGGCACTGCCGAC-3'). Both primers contain an EcoRI site at the 5' end of the coding sequence or after the stop codon. The polymerase chain reaction product was purified from agarose gels, cut with EcoRI, and cloned into an EcoRI digested pKK223-3 expression vector. Expression of MutM protein was similar to that of M25 as mentioned above. MutM protein was purified to more than 95% homogeneity from E. coli JM109 cells harboring the overproduction plasmid by ammonium sulfate precipitation, phosphocellulose, hydroxylapatite, and heparin chromatographies similar to the method used with MutY enzyme (7).

Oligonucleotide Substrates and Enzymes-- The nucleotide sequences of oligonucleotide pairs used in this study were as follows: 19-mer 5'-CCGAGGAATTXGCCTTCTG-3' and 3'-GCTCCTTAAYCGGAAGACG-5' and 40-mer 5'-AATTGGGCTCCTCGAGGAATTXGCCTTCTGCAGGCATGCC-3'and 3'-CCCGAGGAGCTCCTTAAYCGGAAGACGTCCGTACGGGGCC-5' (X = A, C, G, T, I, or U; Y = C, G, or GO). Oligonucleotides of 19-mer and 40-mer containing base mismatches were labeled at the 3' or 5' ends as described by Lu et al. (20). After filling-in the sticky ends with the Klenow fragment of DNA polymerase I, the 19-mer and 40-mer were converted into 20-mer and 44-mer, respectively. DNA substrates containing U/G or U/GO (300 fmol) were fully converted to AP/G or AP/GO by treating with 1.5 units of E. coli uracil DNA glycosylase (UDG, Life Technologies, Inc.) at 37 °C for 1 h in MutY buffer (20 mM Tris-HCl, pH 7.6, 80 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, and 2.9% glycerol).

MutY Binding, Trapping, and Cleavage Assays-- The MutY activity assays with labeled oligonucleotide substrates were performed as described by Lu et al. (38) with some modifications. MutY enzyme was diluted with diluent (20 mM potassium phosphate, pH 7.4, 50 mM KCl, 1.5 mM dithiothreitol, 0.1 mM EDTA, 200 µg/ml bovine serum albumin, and 50% glycerol) before use. The MutY binding reaction mixture contains 20 mM Tris-HCl, pH 7.6, 80 mM NaCl, 1 mM dithiothreitol, 1 mM EDTA, 2.9% glycerol, 20 ng of poly(dI-dC), and 1.8 fmol of labeled DNA in a total volume of 10 µl. After incubation at 37 °C for 30 min, the mixtures were supplemented with 1.5 µl of 50% glycerol and analyzed on 8% polyacrylamide gels in 50 mM Tris borate, pH 8.3, and 1 mM EDTA. To determine the Kd values, nine different MutY enzyme concentrations were used to bind DNA substrates and experiments were repeated at least three times. Bands corresponding to enzyme-bound and free DNA were quantified from PhosphorImager images and Kd values were obtained from analyses by a computer-fitted curve generated by the Enzfitter program (49).

Covalent complexes of M25 and MutY with 19-mer DNA substrates were formed in a reaction containing 20 mM Tris-HCl, pH 7.6, 1 mM dithiothreitol, 1 mM EDTA, 2.9% glycerol, and 0.1 M NaBH4. A NaBH4 (1 M) stock solution was freshly prepared and added immediately after the enzyme was added. After incubation at 37 °C for 30 min, 5× dye buffer (0.5 M sucrose, 15% SDS, 312.5 mM Tris-HCl, pH 6.9, 10 mM EDTA, 5% beta -mercaptoethanol, and 0.0025% bromphenol blue) was added to the samples, which were heated at 90 °C for 2 min and separated on a 12% polyacrylamide gel in the presence of SDS according to Laemmli (50).

The glycosylase assays were carried out similarly to the trapping assay except no NaBH4 was added. After incubation at 37 °C for various times, reaction mixtures were lyophilized, resuspended in 3 µl of formamide dye (90% formamide, 10 mM EDTA, 0.1% xylene cyanol, and 0.1% bromphenol blue), heated at 90 °C for 2 min, and loaded onto 14% 7 M urea sequencing gels. For time course studies, after enzyme reaction at different time points, samples were immediately frozen at -70 °C, followed by heating at 90 °C for 30 min with 1 M piperidine, and then treated as the glycosylase reaction.

MutM Cleavage of T/GO-, C/GO-, G/GO, and AP/GO-containing Substrates-- The reaction mixture contained 1.8 fmol of duplex 20-mer DNA substrates and 0.09 nM MutM for C/GO, T/GO, and G/GO mismatches and 0.36 nM MutM for AP/GO mismatch, respectively, in the MutY buffer. The reaction was preincubated for 2 min at room temperature with increasing amounts of MutY, M25, or diluent. MutM was then added, and the reaction was further incubated at 37 °C for 28 min. Samples after reactions were lyophilized, resuspended in 3 µl of formamide dye, heated at 90 °C for 2 min, and loaded onto 14% 7 M urea sequencing gels.

Western Blot Analysis-- Proteins were resolved on a SDS-12% polyacrylamide gel and transferred to a nitrocellulose membrane (51). The membrane was subjected to the Enhanced Chemiluminescence analysis system from Amersham Pharmacia Biotech according to the manufacture's protocol. The anti-MutY antibodies were affinity purified by reaction with membrane-bound MutY protein (52).

Measurement of Mutation Frequency-- Independent overnight cultures (0.1 ml) of each strain were plated onto LB agar containing 0.1 mg/ml rifampicin. The cell titer of each culture was determined by plating a 10-6 dilution onto LB agar. For each measurement, four independent cultures were plated and the experiments were repeated three times. The ratio of RifR cells to total cells was the mutation frequency.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

G/GO Is a Substrate for MutY-- We have shown that MutY has much tighter binding, but weaker glycosylase activity to A/GO- than A/G-containing DNA at an enzyme/DNA molar ratio of 40 at 37 °C for 30 min in a steady-state kinetic study (38). To further delineate the reactivity of MutY on different mismatches containing GO, we constructed A/GO, C/GO, G/GO, and T/GO duplex DNA substrates. As shown in Table I, the apparent dissociation constants (Kd) of MutY with A/GO, G/GO, and T/GO are comparable. MutY binding to C/GO-containing DNA was 170-fold weaker than that with A/GO but only 2-fold weaker than that with A/G-containing DNA.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Apparent dissociation constants of M25 and MutY

The combined MutY DNA glycosylase/AP lyase activities can be assayed by monitoring the nicking products in a denatured sequencing gel. As shown in Fig. 1A, MutY adenine glycosylase removed adenines from A/G and A/GO mismatches (Fig. 1A, lanes 2 and 4). DNA substrates containing T/GO and C/GO were not cleaved by MutY (Fig. 1A, lanes 8 and 10). Surprisingly, the duplex containing G/GO was cleaved about 5% of the extent of DNA containing an A/GO mismatch (Fig. 1A, lane 6). A Schiff base intermediate between MutY and DNA can be trapped in a stable enzyme-DNA covalent complex in the presence of sodium borohydride. At an enzyme:DNA molar ratio of 40, MutY could trap A/G and A/GO mismatches efficiently (Fig. 1B, lanes 2 and 4) but not T/GO and C/GO (Fig. 1B, lanes 8 and 10). MutY could also trap the G/GO-containing DNA (Fig. 1B, lane 6) although its efficiency is much weaker (less than 2%) than A/G- and A/GO-DNA (Fig. 1B, lane 6). Thus, MutY is both an adenine and guanine DNA glycosylase.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 1.   MutY glycosylase and trapping activities with DNA substrates. 1.8 fmol of 3'-end labeled A/G (lanes 1 and 2), A/GO (lanes 3 and 4), G/GO (lanes 5 and 6), T/GO (lanes 7 and 8), and C/GO (lanes 9 and 10) containing 20-mer oligonucleotides were incubated for 30 min at 37 °C with 72 fmol of MutY (even lanes). Odd lanes are DNA alone. A, glycosylase activity. Glycosylase coupled with beta -elimination reaction leads to strand cleavage. The products, after reaction were lyophilized (without piperidine treatment), resuspended in formamide dye, heated at 90 °C for 2 min, and analyzed on a 14% denaturing sequencing gel. Arrows indicate the positions of intact oligonucleotide (I) and the nicked product (N). B, trapping activity. Trapping reactions were performed in the presence of 0.1 M NaBH4 and the products were analyzed on an 8% SDS-polyacrylamide gel. The film was overexposed to show the weak complex of MutY with G/GO mismatch. Arrows indicate the positions of free and enzyme-bound DNA substrates.

DNA Mismatch Binding of M25 and MutY-- Previous results have shown that the N-terminal domain (M25, Met1 to Gln226), obtained from proteolysis of MutY or expressed as a recombinant protein, retains the catalytic activity (39, 47). The tight binding of A/GO mismatch by MutY is lost in M25, suggesting that the C-terminal region of MutY, a region that has no counterpart in E. coli endo III, plays an important role in the recognition of A/GO mismatched DNA. To investigate the function of the C-terminal domain of MutY, the same truncated MutY fragment was overproduced and purified to near homogeneity and its activity was compared with the intact protein. Gel shifting DNA binding experiments demonstrated that recombinant M25 had Kd values of 6.8, 34, and 4.3 nM with A/G-, A/C, and A/GO-containing 20-mer DNA substrates, respectively (Table I, first three rows). The results show that M25 and MutY have similar binding affinities to A/G and A/C mismatches. However, M25 had a 67-fold weaker binding affinity to A/GO-containing DNA than did intact MutY. These results with expressed M25 are consistent with the previous findings of Gogos et al. (39) and Noll et al. (47).

The truncated and intact MutY also had different binding affinities with other mismatches containing GO. As shown in Table I, intact MutY had more than 18-fold higher binding affinities with A/GO, I/GO, G/GO, T/GO, AP/GO, and C/GO mismatches than that of the truncated M25. The largest difference between MutY and M25 is the binding of T/GO- and A/GO-containing DNA substrates. Because T/GO and C/GO are not catalytic substrates of MutY (Fig. 1), the tight binding of these substrates by MutY through its C-terminal domain is surprising. When an AP site was placed opposite G or GO, M25 displayed similar binding affinity to AP/G, but weaker binding affinity to AP/GO relative to the intact enzyme. M25 showed lower binding affinity to DNA substrates containing GO paired with any partner mismatches than intact MutY. Thus, the C-terminal domain of MutY contributes to the high binding affinity of MutY to GO.

Catalytic Activities of M25-- In the trapping assay in the presence of sodium borohydride, expressed M25 protein produced about 2-fold less covalent protein-DNA complex on A/G-containing DNA than intact MutY at the protein/DNA ratios greater than 10 (Fig. 2A, lanes 1-3 and 6-8). At lower protein/DNA ratios, a 2-fold amount of M25 was needed to produce the same amount of complex as MutY. With A/GO mismatch, when M25 was present in large enzyme excess (Fig. 2B, lane 6), the extent of protein-DNA covalent complex formation was 2-fold less than that of intact MutY (Fig. 2B, lanes 1-4). However, the amount of M25 needed to produce the same amount of covalent complex was 40-fold higher than that of intact MutY with A/GO-containing DNA (Fig. 2B, compare lane 5 with lane 9).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 2.   Formation of covalent complexes of MutY and M25 with A/G- and A/GO-containing DNA in the presence of NaBH4. Oligonucleotide substrates (1.8 fmol) were incubated with various amounts of MutY (lanes 1-5) or M25 (lanes 6-10) in the presence of 0.1 M NaBH4 at 37 °C for 30 min. A, trapping reactions with A/G-containing DNA. Lanes 1-5 show results from reactions containing decreasing amounts of MutY (144, 36, 9, 1.8, 0.45 fmol from lane 1 to lane 5, respectively). Lanes 6-10 show results from reactions containing decreasing amounts of M25 (288, 72, 18, 3.6, and 0.9 fmol from lane 6 to lane 10, respectively). B, trapping reactions with A/GO-containing DNA. Lanes 1-5 show results from reactions containing decreasing amounts of MutY (36, 9, 1.8, 0.45, and 0.09 fmol from lane 1 to lane 5, respectively). Lanes 6-10 show results from reactions containing decreasing amounts of M25 (288, 72, 18, 3.6, and 0.9 fmol from lane 6 to lane 10, respectively). Reactions were stopped by adding 5 µl of 3× dye (9 mM Tris-HCl, pH 6.8, 15% glycerol, 3% SDS, 5% beta -mercaptoethanol, and 0.3 mg/ml bromphenol blue) and the products, after heating at 90 °C for 2 min, were electrophoresed on a 12% SDS-PAGE gel. The positions of free DNA (Free) and covalent complexes (C-M25 and C-MutY) are indicated.

Because of the slow turnover rate of MutY (30, 53), the steady-state kinetics of the MutY reaction, as measured at 37 °C for 30 min (33), may not reflect the true reactivity. Thus, we used single-turnover glycosylase kinetics to compare the reactivities of MutY and M25. Time course studies to determine the extent of glycosylase activity on both A/G and A/GO substrates were performed with intact MutY and M25. As shown in Fig. 3A, the rate of cleavage of A/G-containing DNA is similar for both intact MutY (circles) and M25 (diamonds). The times required to reach 50% of Vmax on A/G-containing DNA are 2.1 and 2.7 min for MutY and M25, respectively. However, the rate of cleavage of M25 on A/GO-containing DNA is much slower than that of MutY (Fig. 3B). The times required to reach 50% of Vmax on A/GO-containing DNA are <0.1 and 1.9 min for MutY and M25, respectively. There is a greater than 20-fold difference in reaction rate. The rate of M25 cleavage of A/GO-containing DNA is similar to the rates of MutY and M25 cleavage of A/G-containing DNA (compare diamonds of Fig. 3B to both curves in Fig. 3A). Thus, M25 has reduced rate of glycosylase activity on A/GO-containing DNA, compared with intact MutY.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 3.   Time course studies of MutY and M25 glycosylase activities. A/G (panel A) and A/GO (panel B) containing 20-mer oligonucleotides (1.8 fmol) were incubated at 37 °C with 72 fmol of MutY (circles) or 72 fmol of M25 (diamonds) for various times. The products, after reaction, were treated with piperidine, lyophilized, resuspended in formamide dye, heated at 90 °C for 2 min, and analyzed on a 14% denaturing sequencing gel. Data were from PhosphorImager quantitative analyses of gel images over three experiments. Percentages of DNA cleaved were plotted as a function of time.

The results of Fig. 3 also showed that there was no difference between MutY and M25 when the reactions proceeded for more than 15 min with both A/G and A/GO mismatches. At the steady-state, MutY glycosylase activity with A/GO mismatch is weaker than with A/G-containing DNA. This result is consistent with the previous finding (33).

Inhibition of MutM (Fpg) Activity by MutY and M25-- DNA substrates containing C/GO and T/GO are catalytic substrates of MutM (Fpg) (54) but not of MutY (Fig. 1) although they are bound tightly by MutY (Table I). To explore the significance of these properties, we tried to include MutY in the MutM glycosylase reaction. Both DNA substrates were labeled at the 5' ends of GO-containing strands and preincubated with increasing amounts of MutY before MutM was added. As shown in Fig. 4, A and B, MutY could inhibit MutM activity on both C/GO and T/GO mismatches. MutM activity was reduced to 50% at MutY/MutM ratios of 32 and 0.6 for C/GO and T/GO, respectively (Table II). Because M25 has lower affinities to C/GO and T/GO than does the intact MutY (Table I), it requires a higher amount of enzyme compared with MutY to achieve the same extent of inhibition on MutM activity (Fig. 4, A and B, compare circles and diamonds). MutM activity was reduced to 50% at M25/MutM ratios of 1600 and 80 for C/GO and T/GO mismatches, respectively (Table II). The extent of MutM activity inhibition by MutY and M25 is consistent with the Kd values of these proteins with these substrates.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Inhibition of MutM activity by MutY and M25. Oligonucleotides (labeled at 5'-ends of the GO-strands, 1.8 fmol) containing a C/GO (panel A), T/GO (panel B), G/GO (panel C), or AP/GO (panel D) mismatches were preincubated for 2 min at room temperature with various amounts of MutY, M25, or diluent. MutM was added afterward to a final concentration of 0.09 nM for C/GO, T/GO, and G/GO mismatches and 0.36 nM for AP/GO mismatch, and the reaction was further incubated at 37 °C for 28 min. The products, after reaction were lyophilized (without piperidine treatment), resuspended in formamide dye, heated at 90 °C for 2 min, and analyzed on a 14% denaturing sequencing gel. Data were from PhosphorImager quantitative analyses of gel images from more than three experiments. Percentages of MutM activity relative to without MutY sample were plotted as a function of MutY (circles) or M25 (diamonds) to MutM molar ratios.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Molar ratios of MutY or M25 to MutM required to inhibit 50% of MutM activity

DNA with a G/GO mismatch is a weak substrate of MutY (Fig. 1) but is cleaved very well by MutM (54). When MutY and M25 were added to the MutM reaction with G/GO-containing DNA, strong inhibition was observed (Fig. 4C). MutM activity on G/GO mismatch was reduced to 50% at MutY/MutM and M25/MutM ratio of 0.7 and 6, respectively (Table II). The extent of MutM activity inhibition by MutY and M25 is in agreement with the Kd values of these proteins with the substrate, however, M25 appears to exhibit greater inhibition of MutM activity than as predicted from its Kd value.

AP/GO-containing DNA is a substrate for both MutY and MutM. The AP lyase activity of MutY can cleave at the 3' side of the AP site (37, 45). MutM can excise the GO base and cleave the AP sites on both DNA strands leading to a double-strand break (54). As shown in Fig. 4D, MutY could block MutM cleavage on the GO-strand of AP/GO mismatch. M25, which had an 18-fold lower binding affinity to AP/GO than the intact MutY, inhibited MutM activity on AP/GO to a lesser degree than MutY (Fig. 4D, compare circles and diamonds). MutM activity on AP/GO-containing DNA was reduced to 50% by MutY and M25 at enzyme/MutM ratios of 0.3 and 16, respectively (Table II).

Deletion of C-terminal Domain of MutY Causes a Mutator Phenotype-- The micA (mutY) mutant PR68 was originally isolated in a mutL Su- background and was defective in a repair pathway that removes the adenines from A/G mismatches (5). The mutY mutant strain PR70 (same as PR68 but MutL+) also displays a mutator phenotype (5).

The mutY gene in PR70 is interrupted by a mini Tn10Kan (5) at a site about 750 base pairs downstream from the AUG start codon (22). To determine the exact insertion site of the transposon on this mutant allele, we sequenced the clone, pJTW1-1 (22), bearing micA68 with MutY its own promoter in plasmid pBR322. As shown in Fig. 5A, mini Tn10Kan interrupts at nucleotide 747 of mutY gene followed by a stop codon. PR70 cells should express a 249-residue polypeptide from the N terminus of MutY. As expected, in a Western blot with MutY antibodies, a band at approximately 27 kDa was detected in PR70 and PR70 containing plasmid pJTW1-1 (Fig. 5B, lanes 2 and 3). The 249-residue polypeptide may be less stable or less reactive to the MutY antibodies than the intact MutY as it is hardly detected in the PR70 extract and the truncated protein is present at lower levels in PR70/pJTW1-1 than MutY in PR8 (wild-type) as detected by Western blotting.


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 5.   Characterization of micA68 mutation. A, map of micA68. DNA sequencing of plasmid pJTW1-1 (22) bearing the micA68 mutant mutY gene revealed the mini Tn10 insertion site at nucleotide 747 of the mutY gene and a stop codon immediately after codon 249. A 249-residue polypeptide from the N terminus of MutY was expected to be produced from the interrupted mutY gene. B, Western blotting with MutY antibodies. Extract of PR8 (80 µg) expressed the intact 39-kDa MutY protein (lane 1). A band about 27 kDa was detected in cell extracts (80 µg) from PR70 (lane 2) and PR70 containing pJTW1-1 (lane 3). Purified M25 and MutY proteins were included as markers in lanes 4 and 5, respectively. C, gel shifting assay. A/G- and A/GO-containing 20-mer oligonucleotide was assayed for binding with 10 µg (odd lanes) or 5 µg (even lanes) of cell extracts at 37 °C for 30 min. Lanes 1 and 2, PR8 with A/G-containing DNA; lanes 3 and 4, PR70 with A/G-containing DNA; lanes 5 and 6, PR70/pJTW1-1 with A/G-containing DNA; lanes 7 and 8, PR8 with A/GO-containing DNA; lanes 9 and 10, PR70 with A/GO-containing DNA; lanes 11 and 12, PR70/pJTW1-1 with A/GO-containing DNA. The binding products were analyzed on an 8% native gel in 50 mM Tris borate, pH 8.3, and 1 mM EDTA. Arrows indicate the positions of MutY·DNA complex (B-MutY), micA68·DNA complex (B-micA68), and free DNA (Free).

The extracts of PR68 and PR70 have been shown to be defective in the methylation-independent A/G mismatch repair on phage f1 heteroduplexes and A/G-specific cleavage activity using a 120-mer oligonucleotide substrate (22). When the PR70 extract was re-examined with A/G and A/GO 20-mer DNA substrates, no binding activity could be detected (Fig. 5C, lanes 3-4 and 9-10). Next, we examined MutY binding activity in extracts of PR70 bearing the same mutant allele in plasmid pJTW1-1. Extracts of PR70 containing pJTW1-1 had stronger binding activity with A/G-containing DNA than did PR8 extracts (Fig. 5C, compare lanes 1 and 2 with lanes 5 and 6) although MutY in the PR8 extract was present at higher levels than the truncated protein in the extract of PR70/pJTW1-1 as detected by Western blotting (Fig. 5B, lanes 1 and 3). However, the PR8 extract had much greater binding activity with A/GO-containing DNA then did PR70/pJTW1-1 extract (Fig. 5C, compare lanes 7 and 8 with lanes 11 and 12). Intact MutY in the PR8 extract had much tighter binding with A/GO- than to A/G-containing DNA, however, the truncated protein in the PR70 extract had similar but weak binding with both A/GO and A/G mismatches. Thus, the truncated 249-residue MutY polypeptide encoded by the micA68, as with M25, has lower binding affinity to GO than intact MutY.

The mutation frequency of PR70 has been determined to be more than 40-fold higher than the wild-type cells as measured by the incidence of rifampicin-resistant revertants (5, 55). As shown in Table III, the mutation frequencies of PR70 and PR70/pJTW1-1 was 75- and 32-fold higher than the wild-type cells, respectively. Although the mutation frequency of PR70/pJTW1-1 is not as high as PR70, it displays a mutator phenotype. The phenotype and the biochemical properties of the encoded protein by the micA68 allele strongly support that deletion of the GO-specific C-terminal domain of MutY could lead to a mutator phenotype. It also suggests that repair of A/GO mismatches is the primary role of MutY pathway.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Mutation frequency of E. coli mutY mutant expressing micA68


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

MutY has been identified as an adenine glycosylase that repairs A/G, A/C, and A/GO mismatches (3, 4, 7, 35). Here, we showed that MutY is also a guanine glycosylase repairing G/GO-containing DNA. The binding affinity of MutY with G/GO is slightly lower than that with A/GO-containing DNA but higher than that with A/G-containing DNA. However, the catalytic activity of MutY to G/GO-containing DNA is much lower than that to A/G- and A/GO-containing substrates. The adenine specificity to A/G and A/GO is consistent with the mutation phenotype of mutY mutants for G:C to T:A transversions (3, 5, 56). The weak in vitro A/C and G/GO repair activities of MutY may remove the misincorporated A and G from C and GO on the template strands, respectively. Thus, one may predict that mutY mutants have higher mutation frequencies for C:G to T:A and G:C to C:G. Nghiem et al. (56) and Radicella et al. (5) found that the mutY mutants had higher mutation rates for G:C to T:A transversions but not other types of mutations compared with the wild-type cells. It is possible that A/C and G/GO mismatches are repaired by other pathways such as the MutHLS system. Recently, Zhang et al. (57) found that an E. coli mutY mutant also has an increased mutation rate for G:C to C:G transversions and that MutY has guanine glycosylase activity on G/GO but not G/G mismatches. Their experimental design is similar to that of Nghiem et al. (56) except that the E. coli cells were incubated on glucose minimal media for 10 days instead of 3 days. The delayed mutation accumulation of G:C to C:G transversions may be due to the inefficiency of MutY repair to G/GO mismatches or miscoding of an oxidized form of GO that appeared at the stationary phase (58).

Full-length MutY binds to A/GO-containing DNA 80-fold better than it does to A/G-containing DNA (20). We have shown that the specificity for A/GO binding can be ascribed mainly to the C-terminal domain of MutY, the non-endo III like domain (39). Here, we showed that M25 and MutY have similar binding affinity with an A/G mismatch, however, M25 has much lower affinity to DNA substrates containing GO when paired with any partner mismatches than intact MutY. Thus, the high binding affinity of MutY to GO-containing DNA is contributed mainly by its C-terminal domain. Because MutY has different catalytic activities (Fig. 1) and low turnover rate (30, 53) with these mismatches, the Kd measurement for these substrates may not reflect true equilibrium values. In the case of A/G, A/GO, and A/C, MutY may bind to either the base-base mismatch substrates or the processed products such as AP site or cleaved site. The specific GO-binding role of C-terminal domain of MutY was also described by Noll et al. (47) but not found by Manuel and Lloyd (37). The N-terminal domain (p26) studied by Manuel and Lloyd (37) consists of residues 1-225 which is 1 amino acid shorter than M25 used in this study as well as by Noll et al. (47) and Gogos et al. (39). However, the functional difference between M25 and P26 is probably not derived from 1 amino acid difference.

M25 also has weaker trapping and slower glycosylase activities than MutY with A/GO-containing DNA. When M25 is present in large enzyme excess, the extent of protein-DNA covalent complex formation is about 2-fold less than that of intact MutY (Fig. 2). However, a 40-fold higher amount of M25 is needed to produce the same amount of covalent complex as that of intact MutY with A/GO-containing DNA. At the steady-state, there was no difference in glycosylase activity between MutY and M25 when the reactions proceeded for more than 15 min for both A/G and A/GO. At the pre-steady-state, M25 and MutY have similar rates of glycosylase activity with an A/G mismatch, however, M25 reacts much slower than MutY to an A/GO mismatch. Thus, both the high binding affinity and fast catalytic activity of MutY to GO-containing DNA are contributed mainly by its C-terminal domain. Furthermore, an E. coli mutY strain that produces an N-terminal 249-residue truncated MutY confers a mutator phenotype. The C-terminal mutY deletion allele encodes a polypeptide whose activity is similar to M25. These findings strongly support that the C-terminal domain of MutY is critical for mutation avoidance of oxidative damage. Thus, in vivo, the A/GO mismatches may be the most important substrates of MutY because both prokaryotic and eukaryotic DNA polymerases misinsert A opposite GO at high frequencies (9, 15, 16, 58).

M25, spanning the region homologous with E. coli endo III, is the catalytic domain of MutY (cdMutY) (37, 39, 40). Several DNA binding motifs have been identified in the x-ray crystal structure: a helix-hairpin-helix, a pseudo-helix-hairpin-helix, a positively charged groove with the adenine binding pocket, and an iron-sulfur cluster loop (24). These motifs are responsible for interaction with the DNA phosphates and the mismatched adenine. The crystal structure of the cdMutY also suggests some candidate residues for the recognition of the base opposite the adenine. These include the alpha 2-alpha 3 motif, particularly the conserved Gln41, for the specific recognition of G or GO at a syn configuration through the DNA minor groove. Our results show that the major determinants of the mismatched GO reside in the C-terminal domain of MutY. We propose that the DNA is embedded between the catalytic and C-terminal domains of MutY. In this model, the C-terminal domain functions like a clamp to hold the GO-containing strand. This C-terminal clamp is more open with an A/G mismatch than with an A/GO mismatch. The contacts of MutY with the GO-containing strand may be important for promoting base-flipping of the mismatched A. The residues of the C-terminal domain of MutY involved in this GO specificity remain undetermined. It would be valuable to have the detailed structure of the intact MutY·DNA complex.

Noll et al. (47) pointed out an interesting sequence homology between the C-terminal domain of MutY and MutT. The MutT protein (14 kDa in size) hydrolyzes nucleoside triphosphates, with 8-oxo-dGTP as the best substrate, to nucleoside monophosphates and pyrophosphates (10-12). Both polypeptides are similar in size and can recognize the GO nucleotide. However, the C-terminal domain of MutY by itself has no detectable function (data not shown), unlike MutT. Thus, the C-terminal domain of MutY has evolved to function differently from MutT and it may enhance the N-terminal domain to interact with the phosphate backbone and GO base in DNA.

The tight binding of MutY to T/GO, G/GO, and AP/GO may have biological significance. MutM is able to remove GO from T/GO, G/GO, AP/GO, and C/GO efficiently in vitro (54). It is possible that MutY continues to bind AP/GO mismatches after its glycosylase action in order to prevent removal of GO or cleavage at the AP site by MutM before MutY initiated repair is complete. The inhibition of MutM activity is especially important if T/GO and G/GO mismatches arise from misincorporation of T and G opposite oxidized template guanines as well as if T/GO mismatches are derived from deamination of 5-methylcytosine opposite GO. DNA polymerases may incorporate G or T opposite the GO lesions as suggested by Braun et al. (59). An oxidized form of GO, possibly guanidinohydantoin, may direct misincorporation of dNTPs during DNA synthesis (58). The removal of GO from T/GO and G/GO mismatches when GO is on the parental strands will lead to G:C to A:T transitions and G:C to C:G transversions. Hence, it is reasonable that MutM activity on these unfavorable mismatches is inhibited before other repair pathways remove the base opposite GO. The possible pathways employed to repair these unfavorable mismatches are the long-patch MutHLS mismatch repair and vsr-dependent very short-patch repair (60). Recently, yeast MSH2/MSH6 heterodimer (E. coli MutS homologs) has been shown to bind A/GO mismatches and be involved in GO repair (61). Thus, it is possible that MutS homologs may be involved in repair of T/GO and G/GO mismatches. Our data in Fig. 4 indicate that the MutY protein is involved in this regulation of MutM activity through its C-terminal domain. It has been suggested by Bridges et al. (62) that MutY may regulate MutM activity in resting cells.

Our model for MutY attenuation of MutM activity is shown in Fig. 6. When MutY binds A/G and A/GO, the adenine is flipped out of the DNA helix into the binding pocket and the MutY glycosylase then excises the base (Fig. 6A). When MutY binds T/GO, the T base is not flipped out, no repair occurs, and MutY blocks the MutM binding to this substrate (Fig. 6B). When MutY encounters a G/GO mismatch, the base flipping and repair are very slow; MutY can block the MutM binding when it remains bound to this substrate (Fig. 6C). This additional role of MutY in blocking MutM activity is applicable only when GO is on the parental strands. It is possible that MutY is orientated at the replication fork with the N-terminal domain on the daughter strand and C-terminal domain on the parental strand by an unknown mechanism. With this physical polarity, MutY may repair the misincorporated A opposite template GO but not repair template A opposite misinserted GO.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Model for MutY blockage of MutM activity. DNA strands at the replication fork are represented as lines. The N-terminal and C-terminal domains of MutY are shown in large and small oval-shaped circles, respectively. The gray-filled multi-pointed oval inside the large oval marks the adenine binding pocket. A, MutY binding with A/GO mismatch. When MutY binds A/GO or A/G, the adenine is flipped out of the DNA helix into the binding pocket and the MutY glycosylase then excises the base for repair. B, MutY binding with T/GO mismatch. When MutY binds T/GO, the T base is not flipped out, no repair occurs but MutY blocks the MutM binding to this substrate. C, MutY binding with G/GO mismatch. When MutY encounters a G/GO mismatch, the base flipping and repair are very slow, MutY can block MutM binding because it remains bound to this substrate.


    FOOTNOTES

* This work was supported by United States Public Health Service Grant GM 35132 from the NIGMS, National Institute of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 410-706-4356; Fax: 410-706-1787; E-mail: aluchang@umaryland.edu.

    ABBREVIATIONS

The abbreviations used are: GO (8-oxoG), 7,8-dihydro-8-oxo-guanine; AP, apurinic/apyrimidinic; I, inosine; M25, the N-terminal domain of MutY consisting of residues 1-226; cdMutY or p26, the catalytic domain of MutY consisting of residues 1-225; UDG, E. coli uracil DNA glycosylase; endo III, endonuclease III.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Au, K. G., Cabrera, M., Miller, J. H., and Modrich, P. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9163-9166[Abstract/Free Full Text]
2. Lu, A.-L., and Chang, D.-Y. (1988) Genetics 118, 593-600[Abstract/Free Full Text]
3. Michaels, M. L., Cruz, C., Grollman, A. P., and Miller, J. H. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 7022-7025[Abstract/Free Full Text]
4. Michaels, M. L., Tchou, J., Grollman, A. P., and Miller, J. H. (1992) Biochemistry 31, 10964-10968[CrossRef][Medline] [Order article via Infotrieve]
5. Radicella, J. P., Clark, E. A., and Fox, M. S. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 9674-9678[Abstract/Free Full Text]
6. Su, S.-S., Lahue, R. S., Au, K. G., and Modrich, P. (1988) J. Biol. Chem. 263, 6829-6835[Abstract/Free Full Text]
7. Tsai-Wu, J.-J., Liu, H.-F., and Lu, A.-L. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 8779-8783[Abstract/Free Full Text]
8. Michaels, M. L., and Miller, J. H. (1992) J. Bacteriol. 174, 6321-6325[Free Full Text]
9. Tchou, J., and Grollman, A. P. (1993) Mutat. Res. 299, 277-287[CrossRef][Medline] [Order article via Infotrieve]
10. Maki, H., and Sekiguchi, M. (1992) Nature 355, 273-275[CrossRef][Medline] [Order article via Infotrieve]
11. Akiyama, M., Maki, H., Sekiguchi, M., and Horiuchi, T. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 3949-3952[Abstract/Free Full Text]
12. Bhatnagar, S., and Bessman, M. J. (1988) J. Biol. Chem. 263, 8953-8957[Abstract/Free Full Text]
13. Chetsanga, C. J., and Lindahl, T. (1979) Nucleic Acids Res. 6, 3673-3683[Abstract/Free Full Text]
14. Tchou, J., Kasai, H., Shibutani, S., Chung, M.-H., Grollman, A. P., and Nishimura, S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4690-4694[Abstract/Free Full Text]
15. Shibutani, S., Takeshita, M., and Grollman, A. P. (1991) Nature 349, 431-434[CrossRef][Medline] [Order article via Infotrieve]
16. Wood, M. L., Dizdaroglu, M., Gajewski, E., and Essigmann, J. M. (1990) Biochemistry 29, 7024-7032[CrossRef][Medline] [Order article via Infotrieve]
17. Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., and Loeb, L. A. (1991) J. Biol. Chem. 267, 166-172[Abstract/Free Full Text]
18. Moriya, M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1122-1126[Abstract/Free Full Text]
19. Moriya, M., Ou, C., Bodepudi, V., Johnson, F., Takeshita, M., and Grollman, A. P. (1991) Mutat. Res. 254, 281-288[Medline] [Order article via Infotrieve]
20. Lu, A.-L., Tsai-Wu, J.-J., and Cillo, J. (1995) J. Biol. Chem. 270, 23582-23588[Abstract/Free Full Text]
21. Michaels, M. L., Pham, L., Nghiem, Y., Cruz, C., and Miller, J. H. (1990) Nucleic Acids Res. 18, 3841-3845[Abstract/Free Full Text]
22. Tsai-Wu, J.-J., Radicella, J. P., and Lu, A.-L. (1991) J. Bacteriol. 173, 1902-1910[Abstract/Free Full Text]
23. Nash, H. M., Bruner, S. D., Scharer, O. D., Kawate, T., Addona, T. A., Spooner, E., Lane, W. S., and Verdine, G. L. (1996) Curr. Biol. 6, 968-980[CrossRef][Medline] [Order article via Infotrieve]
24. Guan, Y., Manuel, R. C., Arvai, A. S., Parikh, S. S., Mol, C. D., Miller, J. H., Lloyd, S., and Tainer, J. A. (1998) Nat. Struct. Biol. 5, 1058-1064[CrossRef][Medline] [Order article via Infotrieve]
25. Katcher, H. L., and Wallace, S. S. (1983) Biochemistry 22, 4071-4081[CrossRef][Medline] [Order article via Infotrieve]
26. Bailly, V., and Verly, W. G. (1987) Biochem. J. 242, 565-572[Medline] [Order article via Infotrieve]
27. Yamagata, Y., Kato, M., Odawara, K., Tokuno, Y., Nakashima, Y., Matsushima, N., Yasumura, K., Tomita, K., Ihara, K., Fujii, Y., Nakabeppu, Y., Sekiguchi, M., and Fujji, S. (1996) Cell 86, 311-319[CrossRef][Medline] [Order article via Infotrieve]
28. Labahn, J., Scharer, A., Long, A., Ezaz-Nikpay, K., Verdine, G. L., and Ellenberger, T. E. (1996) Cell 86, 321-329[CrossRef][Medline] [Order article via Infotrieve]
29. Dodson, M. L., Michaels, M. L., and Lloyd, R. S. (1994) J. Biol. Chem. 269, 32709-32712[Free Full Text]
30. David, S. S., and Williams, S. D. (1998) Chem. Rev. 98, 1221-1261[CrossRef][Medline] [Order article via Infotrieve]
31. Dodson, M. L., Shrock, R. D. I., and Lloyd, R. S. (1993) Biochemistry 32, 8284-8290[CrossRef][Medline] [Order article via Infotrieve]
32. Thayer, M. M., Ahern, H., Xing, D., Cunningham, R. P., and Tainer, J. A. (1995) EMBO J. 14, 4108-4120[Medline] [Order article via Infotrieve]
33. Nash, H. M., Lu, R., Lane, W. S., and Verdine, G. L. (1997) Chem. Biol. 4, 693-702[CrossRef][Medline] [Order article via Infotrieve]
34. Sun, B., Latham, K. A., Dodson, M. L., and Lloyd, R. S. (1995) J. Biol. Chem. 270, 19501-19508[Abstract/Free Full Text]
35. Au, K. G., Clark, S., Miller, J. H., and Modrich, P. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 8877-8881[Abstract/Free Full Text]
36. Lu, A.-L., and Chang, D.-Y. (1988) Cell 54, 805-812[CrossRef][Medline] [Order article via Infotrieve]
37. Manuel, R. C., and Lloyd, R. S. (1997) Biochemistry 36, 11140-11152[CrossRef][Medline] [Order article via Infotrieve]
38. Lu, A.-L., Yuen, D. S., and Cillo, J. (1996) J. Biol. Chem. 271, 24138-24143[Abstract/Free Full Text]
39. Gogos, A., Cillo, J., Clarke, N. D., and Lu, A.-L. (1996) Biochemistry 35, 16665-16671[CrossRef][Medline] [Order article via Infotrieve]
40. Manuel, R. C., Czerwinski, E. W., and Lloyd, R. S. (1996) J. Biol. Chem. 271, 16218-16226[Abstract/Free Full Text]
41. Bulychev, N. V., Varaprasad, C. V., Dorman, G., Miller, J. H., Eisenberg, M., and Grollman, A. P. (1996) Biochemistry 35, 13147-13156[CrossRef][Medline] [Order article via Infotrieve]
42. Williams, S. D., and David, S. S. (1998) Nucleic Acids Res. 26, 5123-5133[Abstract/Free Full Text]
43. Zharkov, D. O., and Grollman, A. P. (1998) Biochemistry 37, 12384-12394[CrossRef][Medline] [Order article via Infotrieve]
44. Williams, S. D., and David, S. S. (1999) Biochemistry 38, 15417-15424[CrossRef][Medline] [Order article via Infotrieve]
45. Wright, P. M., Yu, J., Cillo, J., and Lu, A.-L. (1999) J. Biol. Chem. 274, 29011-29018[Abstract/Free Full Text]
46. Golinelli, M.-P., Chmiel, N. H., and David, S. S. (1999) Biochemistry 38, 6997-7007[CrossRef][Medline] [Order article via Infotrieve]
47. Noll, D. M., Gogos, A., Granek, J. A., and Clarke, N. D. (1999) Biochemistry 38, 6374-6579[CrossRef][Medline] [Order article via Infotrieve]
48. Boiteux, S., O'Connor, R. O., and Laval, J. (1987) EMBO J. 6, 3177-3183[Medline] [Order article via Infotrieve]
49. Leatherbarrow, R. J. (1987) Enzfitter: A Nonlinear Regression Analysis Program for IBM PC , Elsevier Science Publisher BV, Amsterdam
50. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
51. Towbin, H. T., Staehlin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354[Abstract/Free Full Text]
52. McGoldrick, J. P., Yeh, Y.-C., Solomon, M., Essigmann, J. M., and Lu, A.-L. (1995) Mol. Cell. Biol. 15, 989-996[Abstract]
53. Porello, S. L., Leyes, A. E., and David, S. S. (1998) Biochemistry 37, 14756-14764[CrossRef][Medline] [Order article via Infotrieve]
54. Tchou, J., Bodepudi, V., Shibutani, S., Antoshechkin, I., Miller, J. H., Grollman, A. P., and Johnson, F. (1994) J. Biol. Chem. 269, 15318-15324[Abstract/Free Full Text]
55. Lu, A.-L., and Fawcett, W. P. (1998) J. Biol. Chem. 273, 25098-25105[Abstract/Free Full Text]
56. Nghiem, Y., Cabrera, M., Cupples, C. G., and Miller, J. H. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2709-2713[Abstract/Free Full Text]
57. Zhang, Q. M., Ishikawa, N., Nakahara, T., and Yonei, S. (1998) Nucleic Acids Res. 26, 4669-4675[Abstract/Free Full Text]
58. Duarte, V., Muller, J. G., and Burrows, C. J. (1999) Nucleic Acids Res. 27, 496-502[Abstract/Free Full Text]
59. Braun, J. E., Wanamarta, A. H., Wientjes, N. M., Wijker, C. A., Lafluer, M. V., and Retel, J. (1997) Mutat. Res. 384, 45-53[Medline] [Order article via Infotrieve]
60. Modrich, P. (1991) Annu. Rev. Genet. 25, 229-253[CrossRef][Medline] [Order article via Infotrieve]
61. Ni, T. T., Marsischky, G. T., and Kolodner, R. D. (1999) Mol. Cell 4, 439-444[CrossRef][Medline] [Order article via Infotrieve]
62. Bridges, B. A., Sekiguchi, M., and Tajiri, T. (1996) Mol. Gen. Genet. 251, 352-357[Medline] [Order article via Infotrieve]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea